ARWR
Price
$17.54
Change
+$0.70 (+4.16%)
Updated
Jul 8, 04:59 PM (EDT)
Capitalization
2.42B
33 days until earnings call
CABA
Price
$1.50
Change
+$0.01 (+0.67%)
Updated
Jul 8, 04:59 PM (EDT)
Capitalization
135.81M
29 days until earnings call
Interact to see
Advertisement

ARWR vs CABA

Header iconARWR vs CABA Comparison
Open Charts ARWR vs CABABanner chart's image
Arrowhead Pharmaceuticals
Price$17.54
Change+$0.70 (+4.16%)
Volume$47.82K
Capitalization2.42B
Cabaletta Bio
Price$1.50
Change+$0.01 (+0.67%)
Volume$15K
Capitalization135.81M
ARWR vs CABA Comparison Chart in %
Loading...
ARWR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CABA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARWR vs. CABA commentary
Jul 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARWR is a Hold and CABA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 09, 2025
Stock price -- (ARWR: $17.54 vs. CABA: $1.51)
Brand notoriety: ARWR: Notable vs. CABA: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARWR: 115% vs. CABA: 71%
Market capitalization -- ARWR: $2.42B vs. CABA: $135.81M
ARWR [@Biotechnology] is valued at $2.42B. CABA’s [@Biotechnology] market capitalization is $135.81M. The market cap for tickers in the [@Biotechnology] industry ranges from $309.49B to $0. The average market capitalization across the [@Biotechnology] industry is $2.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARWR’s FA Score shows that 1 FA rating(s) are green whileCABA’s FA Score has 1 green FA rating(s).

  • ARWR’s FA Score: 1 green, 4 red.
  • CABA’s FA Score: 1 green, 4 red.
According to our system of comparison, both ARWR and CABA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARWR’s TA Score shows that 4 TA indicator(s) are bullish while CABA’s TA Score has 3 bullish TA indicator(s).

  • ARWR’s TA Score: 4 bullish, 4 bearish.
  • CABA’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, ARWR is a better buy in the short-term than CABA.

Price Growth

ARWR (@Biotechnology) experienced а +9.01% price change this week, while CABA (@Biotechnology) price change was -3.21% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.39%. For the same industry, the average monthly price growth was +14.41%, and the average quarterly price growth was +12.94%.

Reported Earning Dates

ARWR is expected to report earnings on Dec 01, 2025.

CABA is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Biotechnology (+9.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARWR($2.42B) has a higher market cap than CABA($136M). ARWR YTD gains are higher at: -6.702 vs. CABA (-33.480). ARWR has higher annual earnings (EBITDA): -68.12M vs. CABA (-123.92M). ARWR has more cash in the bank: 1.1B vs. CABA (132M). CABA has less debt than ARWR: CABA (28.8M) vs ARWR (388M). ARWR has higher revenues than CABA: ARWR (545M) vs CABA (0).
ARWRCABAARWR / CABA
Capitalization2.42B136M1,781%
EBITDA-68.12M-123.92M55%
Gain YTD-6.702-33.48020%
P/E RatioN/AN/A-
Revenue545M0-
Total Cash1.1B132M831%
Total Debt388M28.8M1,347%
FUNDAMENTALS RATINGS
ARWR: Fundamental Ratings
ARWR
OUTLOOK RATING
1..100
7
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
55
P/E GROWTH RATING
1..100
2
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ARWRCABA
RSI
ODDS (%)
Bearish Trend 7 days ago
81%
Bearish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 7 days ago
80%
Bullish Trend 6 days ago
87%
Declines
ODDS (%)
Bearish Trend 22 days ago
83%
Bearish Trend 9 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ARWR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CABA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WHIYX5.95N/A
N/A
Macquarie High Income Fund Class Y
EMAAX15.99N/A
N/A
Gabelli Entpr Mergers & Acquisitions A
FBLEX14.27N/A
N/A
Fidelity Series Stk Selec Lg Cp Val
MRRGX34.98N/A
N/A
Meridian Growth Institutional
AFOIX18.43N/A
N/A
Alger Mid Cap Focus I

ARWR and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARWR has been loosely correlated with DNLI. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if ARWR jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARWR
1D Price
Change %
ARWR100%
+4.16%
DNLI - ARWR
55%
Loosely correlated
+0.56%
IMNM - ARWR
54%
Loosely correlated
-1.61%
RGNX - ARWR
53%
Loosely correlated
+3.68%
YMAB - ARWR
53%
Loosely correlated
-0.24%
BEAM - ARWR
52%
Loosely correlated
+5.84%
More

CABA and

Correlation & Price change

A.I.dvisor indicates that over the last year, CABA has been loosely correlated with IPSC. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if CABA jumps, then IPSC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CABA
1D Price
Change %
CABA100%
+1.34%
IPSC - CABA
43%
Loosely correlated
+2.25%
KYTX - CABA
43%
Loosely correlated
+10.59%
ARCT - CABA
43%
Loosely correlated
+3.29%
RNA - CABA
41%
Loosely correlated
+1.56%
OCUL - CABA
41%
Loosely correlated
+3.23%
More